financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Visteon Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Visteon Corporation
Apr 25, 2024 6:47 AM

09:20 AM EDT, 04/25/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target by $10 to $140 on a '25 P/E of 14.0x, a steep but justified discount to VC's 10-year mean forward P/E of 36.3x. We lower our adjusted EPS estimates to $8.25 from $8.60 for '24 and to $10.00 from $10.35 for '25. VC posted Q1 adjusted EPS of $1.61 vs. $1.25 (+29%), short of the $1.68 consensus. The miss was driven by weaker-than-expected sales, as revenue fell 3.5% to $933M ($40M below consensus) and adjusted EBITDA margin expanded 70 bps to 10.9% (10 bps ahead of consensus). VC maintained its full-year sales and adjusted EBITDA guidance of $4.0B-$4.2B and $470M-$500M, respectively, which compares to the current consensus of $4.1B and $482M, respectively. With $7.2B in new business wins in 2023 (up from $6B in 2022) and one of the strongest growth outlooks of any auto supplier, VC remains one of our top picks. After an 11% YTD decline, VC is trading at a steep discount to its historic average P/E and a modest rebound in its multiple implies significant upside from current levels.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Hold Opinion On Shares Of 10x Genomics, Inc.
Research Alert: CFRA Retains Hold Opinion On Shares Of 10x Genomics, Inc.
Aug 10, 2025
12:40 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our target price at $12, based on our DCF analysis. We update our 2025 adjusted loss per share (LPS) view to $0.02 (from an LPS of $0.99). We...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Markel Group, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Markel Group, Inc.
Aug 10, 2025
01:05 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our $2,000 target price, based on 18.8x our 2026 operating EPS estimate of $106.15 (cut by $4.70) and at 20.9x our 2025 EPS estimate of $95.56 (down by...
Research Alert: CFRA Reiterates Strong Sell Opinion On Shares Of Tripadvisor, Inc.
Research Alert: CFRA Reiterates Strong Sell Opinion On Shares Of Tripadvisor, Inc.
Aug 11, 2025
10:15 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $1 to $13, 10x our 2026 EPS estimate (from 10x our 2025 EPS view). The multiple reflects the extended timeline for TRIP's transformation...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Virgin Galactic Holdings, Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of Virgin Galactic Holdings, Inc.
Aug 9, 2025
01:05 PM EDT, 08/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $3, applying an EV/revenue multiple of 0.7x to our 2026 estimate, a slight discount to peers, reflecting cash burn and delays to its...
Copyright 2023-2025 - www.financetom.com All Rights Reserved